Skip to content
Bored Studies
RecruitingAccepts healthy volunteersEarly Phase 1

Cocaine and Pentoxifylline (BED IN 47)

William Stoops · with National Institute on Drug Abuse (NIDA) · NCT07086794

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Early Phase 1
Target enrollment
30
US sites recruiting
1
Study start
November 10, 2025
Record last updated
June 8, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This will be a human laboratory study evaluating the influence of pentoxifylline treatment on the effects of cocaine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.

Being studied: Placebo; Cocaine (IV); Pentoxifylline

Conditions: Cocaine Use Disorder

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • able to speak/read English,
  • not seeking treatment for drug use at the time of the study,
  • female or male between the ages of 18 and 55 years,
  • recent smoked or intravenous cocaine use verified by benzoylecgonine positive urine, as well as fulfillment of DSM-5 diagnostic criteria for CUD,
  • judged to be medically and psychiatrically healthy by study physicians other than the diagnosis for CUD at the time of screening,
  • ECG, read by a cardiologist, within normal limits,
  • females using an effective form of birth control and not pregnant or breastfeeding and 8) no known contraindications or allergies to pentoxifylline.

Exclusion Criteria

  • unable to speak/read English,
  • seeking treatment for drug use,
  • under 18 years or over 55 years,
  • no recent smoked or intravenous cocaine use as indicated by benzoylecgonine negative urine and no DSM-5 diagnosis of CUD,
  • judged to be medically or psychiatrically unhealthy by study physicians at the time of screening,
  • ECG, read by a cardiologist, outside normal limits,
  • females not using an effective form of birth control or pregnant or breastfeeding,
  • contraindications or allergies to pentoxifylline, and
  • Self-reported history of head trauma, seizure, CNS tumors, or use of concomitant medications that lower seizure threshold, or first-degree family history of seizures.

Recruiting US locations

  • Psychopharmacology of Addiction Laboratory

    Lexington, KY 40507

    Site contact: William W Stoops, PhD · 859-257-5388 · william.stoops@uky.edu

Study contacts (from the official record)

  • William W Stoops, PhD · 859-257-5388 · william.stoops@uky.edu
Cocaine and Pentoxifylline (BED IN 47) (NCT07086794) | Bored Studies